June 29, 2020 / 7:39 AM / 17 days ago

BioNTech raises $250 million from investors including Temasek

FRANKFURT, June 29 (Reuters) - BioNTech said Singapore's state investment company Temasek and other investors are injecting $250 million into the German biotech firm through a private placement.

The company, which is developing a COVID-19 vaccine, said the transaction includes the purchase of about $139 million in ordinary shares and a $112 million investment in 4-year mandatory convertible notes.

Reporting by Ludwig Burger; editing by Thomas Seythal

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below